Olivia Carr
Physician Assistant · Laguna Hills, CANPI 1730810490
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,507, 4.5 times the $334 reported in 2022. Among physician assistant clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $18.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$737
- Antares Pharma, Inc.$685
- Teleflex LLC$428
- AbbVie$193
- Boston Scientific$185
- Tolmar, Inc.$179
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,824100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 35 | $737 |
| Antares Pharma, Inc. | 93 | $685 |
| Teleflex LLC | 12 | $428 |
| AbbVie | 8 | $193 |
| Boston Scientific | 3 | $185 |
| Tolmar, Inc. | 9 | $179 |
| Procept Biorobotics Corporation | 1 | $153 |
| Pfizer | 7 | $137 |
| Astellas Pharma US Inc | 6 | $135 |
| Merck | 5 | $123 |
| Bluewind Medical | 1 | $122 |
| Astellas Pharma Global Development | 2 | $106 |
| Johnson & Johnson | 2 | $88 |
| Medtronic | 2 | $81 |
| AstraZeneca | 2 | $70 |
| Laborie Medical Technologies Corp. | 2 | $50 |
| Urovant Sciences Inc | 2 | $47 |
| Axonics, Inc. | 2 | $43 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Urogen Pharma, Inc. | 1 | $27 |
| Immunitybio, Inc. | 1 | $26 |
| Bayer | 1 | $24 |
| Acerus Pharmaceuticals Corporation | 2 | $24 |
| Accord Healthcare, Inc. | 1 | $24 |
| Halozyme Inc | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$153
- AMS 700$150
- XYOSTED$110
- UroLift$108
How this compares
$3,824 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 141 | $111,110 |
| MyrbetriqMirabegron | 89 | $57,132 |
| Estradiol | 181 | $12,935 |
| EstringEstradiol | 21 | $10,941 |
| Methenamine Hippurate | 129 | $10,851 |
| PremarinEstrogens, Conjugated | 12 | $5,242 |
| Solifenacin Succinate | 91 | $3,831 |
| Cefdinir | 145 | $2,848 |
| Testosterone | 31 | $2,357 |
| Tamsulosin Hcl | 175 | $2,118 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 91 | $1,749 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 135 | $1,438 |
| Silodosin | 21 | $1,076 |
| Finasteride | 111 | $1,065 |
| NitrofurantoinNitrofurantoin Macrocrystal | 18 | $880 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $737 | $111,110141 claims |
| Astellas Pharma US IncMyrbetriq | $135 | $57,13289 claims |
| PfizerEstring, Premarin | $137 | $16,18333 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Laguna Hills
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Andrea FoxStanford$172K
- Asma HussainiThousand Oaks$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.